Start Date
February 28, 2001
Primary Completion Date
January 31, 2002
Study Completion Date
January 31, 2002
ixabepilone
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER